Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections

Histopathology

Volumn 57, Issue 1, 2010, Pages 14-26

  Fleskens, Stijn J H M ^a   Takes, Robert P ^a   Otte Höller, Irene ^a   Van Doesburg, Lisanne ^a   Smeets, Annemieke ^a   Speel, Ernst Jan M ^b   Slootweg, Pieter J ^a   Van Der Laak, Jeroen A W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

biomarkers; digital image analysis; DNA ploidy analysis; fluorescence microscopy; Ki 67 proliferation marker; oral premalignancies

Indexed keywords

BIOLOGICAL MARKER; HISTONE H2AX; HISTONE H2AX GAMMA; KI 67 ANTIGEN; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; DNA; H2AFX PROTEIN, HUMAN; HISTONE; MIB-1 ANTIBODY; MONOCLONAL ANTIBODY; PARAFFIN; TUMOR MARKER;

ANEUPLOIDY; ARTICLE; CANCER GROWTH; CELL NUCLEUS; CLINICAL ARTICLE; DOUBLE STRANDED DNA BREAK; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MOUTH CANCER; PHENOTYPE; PLOIDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; SENSITIVITY AND SPECIFICITY; TECHNIQUE; TISSUE SECTION; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHEMISTRY; DIAGNOSTIC USE; GENETICS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDY;

ANEUPLOIDY; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MOUTH NEOPLASMS; PARAFFIN EMBEDDING; PLOIDIES; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77954549221     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03599.x     Document Type: Article

References (42)

1. Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN. The molecular biology of esophageal adenocarcinoma. J. Surg. Oncol. 2005 92 169 190.
2. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004 432 338 341.
3. Reid BJ, Blount PL, Rabinovitch PS. Biomarkers in Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 2003 13 369 397.
4. Robinson JK, Rademaker AW, Goolsby C, Traczyk TN, Zoladz C. DNA ploidy in nonmelanoma skin cancer. Cancer 1996 77 284 291.
5. Smits T, Olthuis D, Blokx WA et al. Aneuploidy and proliferation in keratinocytic intraepidermal neoplasias. Exp. Dermatol. 2007 16 81 86.
6. Yu C, Zhang X, Huang Q, Klein M, Goyal RK. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus. Lab. Invest. 2007 87 466 472.
7. Levine DS, Rabinovitch PS, Haggitt RC et al. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 1991 101 1198 1210.
8. Abou-Elhamd KE, Habib TN. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncol. 2007 43 366 372.
9. Veltman JA, Bot FJ, Huynen FC, Ramaekers FC, Manni JJ, Hopman AH. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J. Clin. Oncol. 2000 18 1644 1651.
10. Kerkhof M, Steyerberg EW, Kusters JG et al. Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer Biomark. 2008 4 1 10.
11. Garrity MM, Burgart LJ, Mahoney MR et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J. Clin. Oncol. 2004 22 1572 1582.
12. Haroske G, Baak JP, Danielsen H et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal. Cell. Pathol. 2001 23 89 95.
13. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 1983 31 1333 1335.
14. Dodd LG, Kerns BJ, Dodge RK, Layfield LJ. Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters. J. Surg. Oncol. 1997 64 280 287.
15. Huang Q, Yu C, Zhang X, Goyal RK. Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma. BMC Clin. Pathol. 2008 8 5.
16. Gauthier ML, Berman HK, Miller C et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 2007 12 479 491.
17. Susnik B, Poulin N, Phillips D, LeRiche J, Palcic B. Comparison of DNA measurement performed by flow and image cytometry of embedded breast tissue sections. Anal. Quant. Cytol. Histol. 1995 17 163 171.
18. Freed JA. Improved correction of quantitative nuclear DNA (ploidy) measurements in tissue sections. Anal. Quant. Cytol. Histol. 1999 21 103 112.
19. Forte JD, Croker BP, Hendricks JB. Comparison of histologic and cytologic specimens of urothelial carcinoma with image analysis. Implications for grading. Anal. Quant. Cytol. Histol. 1997 19 158 166.
20. Gschwendtner A, Mairinger T. DNA measurement on histologic slides. Does it work on human tissue?. Anal. Quant. Cytol. Histol. 1997 19 294 300.
21. Klapperstuck T, Wohlrab W. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma. Cytometry 1996 25 82 89.
22. Sapi Z, Hendricks JB, Pharis PG, Wilkinson EJ. Tissue section image analysis of breast neoplasms. Evidence of false aneuploidy. Am. J. Clin. Pathol. 1993 99 714 720.
23. Huang Q, Yu C, Klein M, Fang J, Goyal RK. DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200. BMC Clin. Pathol. 2005 5 7.
24. Ottesen GL, Christensen IJ, Larsen JK et al. DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry. Anal. Quant. Cytol. Histol. 1997 19 413 422.
25. Cattoretti G, Becker MH, Key G et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 1992 168 357 363.
26. Barnes L, Eveson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumours. Pathology and genetics. Head and neck tumours.
27. Hopman AH, Kamps MA, Speel EJ, Schapers RF, Sauter G, Ramaekers FC. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am. J. Pathol. 2002 161 1119 1125.
28. Bergshoeff V, Hopman A, Zwijnenberg I et al. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J. Pathol. 2008 215 347 348.
29. Canny J. A computational approach to edge detection. IEEE Trans. Patern Anal. Mach. Intelligence 1986 8 679 714.
30. Andrejevic-Blant S, Osterheld MC, Caron L, Ballini JP, Monnier P. Deoxyribonucleic acid content as an indicator of progression of squamous cell carcinogenesis in the esophagus: comparative analysis on imprint-cytospin and tissue section preparation. Cancer Detect. Prev. 2006 30 276 283.
31. Williams RA, Baak JP, Meijer GA, Charlton IG. Influence of section thickness, mean nuclear diameter and nuclear crowding on DNA ploidy in histologic sections of melanocytic skin lesions. Anal. Quant. Cytol. Histol. 1999 21 413 424.
32. Uyterlinde AM, Smeulders AW, Baak JP. DNA measurement errors with a scanning microdensitometer in cytologic and histologic samples of breast cancers. Anal. Quant. Cytol. Histol. 1991 13 115 122.
33. Dorman A, Graham D, Curran B, Henry K, Leader M. Ploidy of smooth muscle tumours: retrospective image analysis study of formalin fixed, paraffin wax embedded tissue. J. Clin. Pathol. 1990 43 465 468.
34. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003 63 1727 1730.
35. Koshiji M, Yonekura Y, Saito T, Sakaida N, Uemura Y, Yoshioka K. Genetic alterations in normal epithelium of colorectal cancer patients may be a useful indicator for subsequent metachronous tumor development. Ann. Surg. Oncol. 2002 9 580 586.
36. Tabor MP, Brakenhoff RH, van Houten VM et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin. Cancer Res. 2001 7 1523 1532.
37. Kresty LA, Mallery SR, Knobloch TJ et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002 62 5295 5300.
38. Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol. 2006 59 445 453.
39. True LD, Gao X. Quantum dots for molecular pathology: their time has arrived. J. Mol. Diagn. 2007 9 7 11.
40. Hunter KD, Thurlow JK, Fleming J et al. Divergent routes to oral cancer. Cancer Res. 2006 66 7405 7413.
41. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit. Rev. Oral Biol. Med. 2003 14 47 62.
42. Maley CC, Galipeau PC, Li X et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 2004 64 7629 7633.